Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Oligonucleotide Remove


October 2014
We Tu Mo Su Sa Fr Th
22 21 20 19 18 17 16

oligonucleotide Press Releases

  + XML/RSS  



By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Industry Group Releases Safety Testing Recommendations for Oligonucleotide-Based Therapeutics New Rochelle, NY—Novel oligonucleotide-based drugs in development offer...

By BIOO SCIENTIFIC
Bioo Scientific, an Austin, TX-based biotechnology company was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards.

By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

All Press Releases

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Splice-Switching Oligonucleotide Therapeutics Is Promising New Method for Editing Gene Transcripts New Rochelle, NY—In splice-switching, an innovative therapeutic...

By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc, (914) 740-2100, kruehle@liebertpub.com Industry Group Releases Safety Testing Recommendations for Oligonucleotide-Based Therapeutics New Rochelle, NY—Novel oligonucleotide-based drugs in development offer...

By BIOO SCIENTIFIC
Bioo Scientific, an Austin, TX-based biotechnology company was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards.

By TriLink BioTechnologies, Inc.
Dr. Gerald Zon, noted scientist in the field of nucleic acid research launched a new blog in conjunction with TriLink Biotechnologies. The blog, Zone In with Zon (zon.trilinkbiotech.com), focuses on what's trending in the field of nucleic acids.

By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

By Link Technologies Ltd
AIC to distribute Link’s specialist oligonucleotide modifiers in North America

By Alto Marketing
New survey results highlight the quality of Link’s custom oligo precursors and exceptional customer service

By TriLink BioTechnologies, Inc.
The National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase.

By Biosearch Technologies, Inc
Biosearch Technologies, Inc. today announced that on September 16th, 2009, the company licensed from Roche Molecular Systems (Roche), a family of patents covering practice of the 5’ Nuclease process.

By Dan Dunlop
Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, will present this month at the TIDES 2009 Conference to be held in Las Vegas, NV, May 17-20, 2009.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share